BioSpace News Archive

ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced that the United States Patent and Trademark Office has issued two additional U.S. patents that are directed to the formulation, methods of use and administration of ROMEG’s proprietary colchicine oral solution, which will be marketed as GLOPERBA® and is currently indicated for prophylaxis of gout flares in adults.

Medicinal Genomics Corp. (MGC), a pioneer in genomics and blockchain technology to improve the yield, safety and transparency of cannabis, today announced that Raphael Mechoulam will headline the list of more than 50 speakers and presenters at CannMed 2019, to be held September 23-24 at the Pasadena Convention Center, Pasadena CA.

Webcast to discuss the financial results for the six and three months ended June 30, 2019 and update shareholders on corporate developments.

Affiliates of Signify Health and Remedy Partners, both portfolio companies of New Mountain Capital LLC, have signed a definitive agreement to merge.

Northwest Specialty Hospital in coordination with AxisSpine, PLLC and Globus Medical, Inc. is now offering one of the most advanced and innovative spinal guidance navigation systems in the world.

Thornton Law Firm LLP announces that a lawsuit has been filed on behalf of shareholders of Cardinal Health, Inc. (NYSE ticker: CAH)

Kala Pharmaceuticals, Inc. announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.